These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4642015)

  • 61. [Cardiac muscle participation in the progressive muscle dystrophy of Erb].
    BROGLIE M; JORGENSEN G
    Arztl Wochensch; 1955 Dec; 10(51-52):1175-8. PubMed ID: 13282804
    [No Abstract]   [Full Text] [Related]  

  • 62. On the possibility that a type of human muscular dystrophy commences in myocardium.
    Norris FH; Moss AJ; Yu PN
    Ann N Y Acad Sci; 1966 Sep; 138(1):342-55. PubMed ID: 4226316
    [No Abstract]   [Full Text] [Related]  

  • 63. Introduction: recent advances in hereditary neuromuscular diseases of childhood.
    Bornemann A; Goebel HH
    Brain Pathol; 2001 Apr; 11(2):190-2. PubMed ID: 11303794
    [No Abstract]   [Full Text] [Related]  

  • 64. Cardiomyopathy: presenting symptom of progressive muscular dystrophy.
    Siegel IM
    JAMA; 1972 Nov; 222(8):1060. PubMed ID: 4678951
    [No Abstract]   [Full Text] [Related]  

  • 65. Myocardial impairment in myopathies.
    Pidrman V; Tichý M; Kyral V; Nettl S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1979; 22(4):415-20. PubMed ID: 298019
    [No Abstract]   [Full Text] [Related]  

  • 66. [Myocardial changes in progressive muscular dystrophy].
    van NGUYEN PHAN ; ERDMANN T
    Z Kinderheilkd; 1959; 82():412-7. PubMed ID: 13854105
    [No Abstract]   [Full Text] [Related]  

  • 67. Neuromuscular and chromosomal co-morbidity in LV non-compaction/ hypertrabeculation.
    Stöllberger C; Finsterer J
    Isr Med Assoc J; 2010 Feb; 12(2):127-8. PubMed ID: 20552733
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical characteristics of myocardial dystrophies and myocardiopathies].
    Sumarokov AV
    Kardiologiia; 1978 May; 18(5):5-13. PubMed ID: 671994
    [No Abstract]   [Full Text] [Related]  

  • 69. NOTCH2NLC-related oculopharyngodistal myopathy type 3 with cardiomyopathy and nephropathy.
    Gu X; Yue D; Qiao K; Huang G; Zhu W; Xi J; Zhu H
    Muscle Nerve; 2023 May; 67(5):E18-E21. PubMed ID: 36840947
    [No Abstract]   [Full Text] [Related]  

  • 70. Abnormalities of Skin and Cutaneous Appendages in Neuromuscular Disorders.
    Finsterer J; Wakil S
    Pediatr Neurol; 2015 Oct; 53(4):301-8. PubMed ID: 26385056
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Muscular dystrophy and related diseases. Proceedings of the Second Australian Rotary Health Research Fund Conference. Sydney, 26-28 November 1986.
    Aust Paediatr J; 1988; 24 Suppl 1():1-115. PubMed ID: 3202734
    [No Abstract]   [Full Text] [Related]  

  • 72. Neurological complications of cardiomyopathies.
    Fonseca AC; Almeida AG; Santos MO; Ferro JM
    Handb Clin Neurol; 2021; 177():91-109. PubMed ID: 33632460
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Course of a model cutaneous inflammation on the cellular level in neuro-muscular disease].
    Urbánek K; Jansa P; Steidl L; Jandová D
    Cesk Neurol Neurochir; 1975 Dec; 38(6):333-7. PubMed ID: 1104204
    [No Abstract]   [Full Text] [Related]  

  • 74. Report of the 95th European Neuromuscular Centre (ENMC) sponsored international workshop cognitive impairment in neuromuscular disorders, Naarden, The Netherlands, 13-15 July 2001.
    D'Angelo MG; Bresolin N
    Neuromuscul Disord; 2003 Jan; 13(1):72-9. PubMed ID: 12467736
    [No Abstract]   [Full Text] [Related]  

  • 75. Nemaline myopathy presenting as cardiomyopathy.
    Meier C; Gertsch M; Zimmerman A; Voellmy W; Geissbühler J
    N Engl J Med; 1983 Jun; 308(25):1536-7. PubMed ID: 6855830
    [No Abstract]   [Full Text] [Related]  

  • 76. Editorial commentary: Preserving myocardium in muscular dystrophy patients using ACE inhibition.
    Taylor MD
    Trends Cardiovasc Med; 2018 Jul; 28(5):338-339. PubMed ID: 29574046
    [No Abstract]   [Full Text] [Related]  

  • 77. Facioscapulohumeral syndrome with cardiomyopathy.
    Topaloğlu H; Celiker A; Ozme S; Göğüs S; Gücüyener K; Erdinc OO; Ozdirim E
    Postgrad Med J; 1990 Dec; 66(782):1088-9. PubMed ID: 2084666
    [No Abstract]   [Full Text] [Related]  

  • 78. Clinical semiology of neuromuscular diseases (3).
    Serratrice J; Serratrice G
    Acta Myol; 2006 Oct; 25(2):49-52. PubMed ID: 18593004
    [No Abstract]   [Full Text] [Related]  

  • 79. Neuromuscular diseases: therapeutic advances.
    Miller RG
    Lancet Neurol; 2008 Jan; 7(1):12-4. PubMed ID: 18093551
    [No Abstract]   [Full Text] [Related]  

  • 80. [Myocardiopathies].
    Tanaka H
    Nihon Naika Gakkai Zasshi; 1999 Feb; 88 Suppl():50-4. PubMed ID: 10341606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.